Speech by the Chancellor at the Association Conference of the Chemical Industry "The Chemical Industry is the Foundation of Our Success"

Germany Olaf Scholz · Member of the Bundestag

12 September 2024 · Association Conference of the Chemical Industry (VCI)

Context
Scholz addressed the VCI Association Conference on September 12, 2024, emphasizing the chemical industry's role in Germany's industrial and research success.
Main themes
Chemical industry as industrial foundation, research and development investment, PFAS regulation and alternatives, REACH regulation reform, bureaucracy reduction, energy transition and green chemistry, tax incentives for R&D, EU regulatory policy, planning security for industry, export competitiveness, innovation and sustainability
Duration
~26 min
77th percentile
Words
3,107
77th percentile
Sentences
157
82nd percentile
Readability
51
66th percentile
Grade
10.9
31st percentile
Syntax
2.97
43rd percentile
Vocabulary
2.08
22nd percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Economic 52%50%
  • Institutional 17%17%
  • Ceremonial 13%13%
  • Environmental 9%8%
  • Social 5%4%
  • Geopolitical 2%2%
  • Technological 2%2%
  • Not in focus 4%

157 sentences in 38 paragraphs

Dear Mr. Steilemann, I have heard that you were re-elected as President of the VCI this morning. All I can say is: Congratulations!

Dear Mr. Große Entrup,

dear VCI Presidium,

dear Birgit Biermann,

dear Katja Scharpwinkel,

ladies and gentlemen,

Chemistry is the beginning of everything. Once you realize this, it becomes very clear why we are here today. Without chemistry, there would be no life. But without chemistry, there would also be no industry. From the basic materials industry, all the cars we drive, all the machines we export, microchips, polymers, and pharmaceuticals are produced. Therefore, the chemical industry is the foundation of our success as an industrial nation.

Our industry is successful because it is constantly evolving. Three weeks ago, I was in Marl at Evonik. We looked at the Rheticus plant together. It uses CO2 as a raw material for specialty chemicals. This means that less fossil raw materials are needed when producing specialty chemicals.

This shows two things. First: Chemistry can be produced in an environmentally friendly way in our country, not only here but also around the world. – Second: Research works.

The Rheticus project is part of the Copernicus projects, one of the major research initiatives for the energy transition. It demonstrates that good ideas from research can quickly be transformed into concrete products in collaboration with industry.

The pace is what matters. Companies and the state are investing more than 120 billion euros in research and development in Germany. This is also proportionally as much as no other of the major economies in Europe does. This is and remains the basis of our success. When it is sometimes asked why Germany has such great export successes, many reasons can be given, but the high share of research and development is the central foundation for it. When discussions arise in other nations about where these exports come from and whether we are doing something wrong, the answer is: It must be the same everywhere.

Perhaps I may mention the comparison that has always preoccupied me: When you look at the ranking of nations in the world and their spending on research and development, you find that the USA and China are followed by Japan and Germany. However, if the entire European Union spent as much of its economic output on research and development as Germany does, Europe would be at the forefront. But that is not the case. Therefore, it is something very special that we have it this way, and it is also our central task to ensure that this remains possible for the future.

That is why we have improved and expanded the tax research grants. Just recently, we increased the maximum grant again, at least as a legislative proposal from the federal government, to 4.2 million euros per year for small and medium-sized enterprises, which significantly shape the chemical industry in Germany. It is important that this comes into effect soon.

But I am also aware of your current study, which shows that German chemical companies are increasingly establishing their research in other countries. They cite low costs, better funding programs, and less bureaucracy than in Germany as reasons. Regarding the reduction of bureaucracy here in Germany, which has been discussed for many decades and about which you have heard many political speeches without feeling that anything has changed for you, I will come to that shortly. Fortunately, since we have a large domestic market, we regulate many things together in Brussels, for example, PFAS and the REACH regulation. I must speak about that here.

PFAS are known as forever chemicals because they do not break down in the environment, are partly toxic, and thus pose a problem, which, by the way, I think no one questions. However, there are still no alternatives for many of them. That is why your research on innovations and alternatives for PFAS is so important, ladies and gentlemen.

However, we reject an undifferentiated total ban on all these chemical groups. Where the use of PFAS is harmful and better alternatives exist, the substances should be banned. Where there are still no alternatives and their benefits outweigh the drawbacks, their use must remain possible, for example, in medical devices, semiconductors, or electrolyzers. Until alternatives are available, we therefore need transition periods and exceptions. It is also important to us – this is a consensus in the federal government – that the risk-based approach should be maintained in the amendment of the REACH regulation. This is also a demand from you, and we clearly commit to it. For both REACH and PFAS, we advocate for a practical and balanced regulation for you. You can rely on this for the future as well. In the Brussels jungle, it is important to have a clear compass.

One thing is clear: Industry needs planning security. – The federal government will therefore continue to engage with you on this from the Chancellery, just as we have been doing all along.

Germany is a central location for the chemical industry in the world. I want that to remain the case. That is why I invited you to the Chemical Summit at the Chancellery a year ago. We talked together, large chemical companies and SMEs, associations and trade unions, selected federal states, and the relevant ministries of the federal government. The meeting was the kickoff for a year of substantive work. That has been done. Therefore, I am pleased that today a few words can be said about the chemical strategy with which we want to strengthen the chemical location. To all who have contributed to this, I would like to take this opportunity to thank you for your expertise, your input, and all your commitment. Without that, it would not have been possible. Thank you for your work!

From my perspective, there are five important results. We reject an undifferentiated total ban on chemical groups. I have just explained why we find this correct regarding PFAS. We are reducing bureaucratic hurdles. We are promoting the circular economy and research on innovations. We are strengthening – this is also a topic we have discussed a lot – STEM education in the school career for the skilled workers we will need in the future. Because it is central that we always have enough women and men who want to work in these areas. Fifth, we have extended the electricity price compensation until 2030, which was important, is secured, and is central for planning security, and we will advocate with the European Commission for further areas of the economy to be relieved. Because we have to get approval for such an exception each time. We have looked very closely at which areas have companies where it is not really clear why they should not also benefit from it. All of this is particularly beneficial for an energy-intensive industry like chemistry. Because even if studies yield different results, it is clear that your electricity demand will increase.

In addition, we will advocate that companies that cannot flexibly adjust their electricity consumption continue to have affordable grid fees. This is a central issue, the urgency of which we have understood very well and about which we have discussed a lot. We want to contribute to making this possible. Therefore, we are also striving for a state aid-compliant extension of the regulation – now it gets very technical – of Section 19, Paragraph 2 of the Electricity Network Charge Regulation. I am being precise because many experts are sitting here who know exactly what it is about. The public must then accept that such a detail is being discussed. It is important. We want to extend the relief effect as much as possible. It is necessary. We have this industry, and we want it, and therefore the conditions must also be right. With the electricity price compensation and the reduction of the electricity tax to the European minimum, your companies can now plan long-term.

A long-term secure, affordable, and sustainable energy supply also includes renewable energies. We are seeing growth rates that hardly anyone thought possible two years ago. In the first half of this year, the share of renewable energies in electricity generation was already over 60 percent. It is to be 80 percent by 2030. So it is not wishful thinking that we will actually get there, and this must always be added – with increasing electricity production.

Real progress has also been made in the expansion of the grid. Of the 14,000 kilometers of new power lines that have been legally mandated so far, over a third are now under construction or approved. Compared to the end of 2019, we have doubled the expansion figures. This is just the beginning. Because we are encouraged by the results of legislative deregulation consequences to continue to push for things to be approved quickly and to achieve the pace we need.

Pace is crucial, and we also need more pace in modernizing our industry. The transition to climate-friendly production is certainly the biggest change in our economy since the beginning of industrialization – I believe it cannot be formulated any smaller, and therefore it must be said that way. That is why we will stand by our companies in this transformation and make it as easy as possible. For this, we are, as already mentioned, reducing bureaucratic hurdles.

Anyone who has ever dealt with the Federal Immission Control Act knows: It lives up to its complex name. It is about something very central, namely the modernization of industrial plants, energy supply, the approval of climate-friendly plants and machines, or electrolyzers that we need for hydrogen production – and many, many other production activities anyway. For all of this, immission control permits are required.

With the current pace and review effort, we and our offices cannot manage it, no matter how hard we try. I have looked into the matter: If you extrapolate it, we would not actually achieve any of the goals we have, and the administrations dealing with it are already at their limit. That is why we have just passed the largest reform of the Federal Immission Control Act in 30 years – very deliberately with this goal of acceleration and simplification. Above all, this is the first reform that does not add any further regulations – I believe this is an old demand of yours – but rather simplifies things.

Together with the states, we have agreed on a pact for accelerating planning and approval, the implementation of which is underway. We have also committed to not always just adding to EU rules but to implement them one-to-one. This also applies to the European Supply Chain Directive, which we are now implementing as we have it, and where we want to quickly make the relief effect that this can bring for aligning the European "level playing field" actually usable. Together with you, the entrepreneurs, we are working closely to ensure that we can continue to attract qualified skilled workers from all over the world.

All of this is important prerequisites for Germany to remain a strong chemical location. I am confident that our new chemical strategy will generate similar impulses as the pharmaceutical strategy, which some know quite well due to the proximity of the companies. It is indeed effective; because companies not only find the pharmaceutical strategy good and the commitment to the pharmaceutical location important, but they are also pleased about less bureaucracy and faster approvals.

In this context, a large environment has also been created to utilize new opportunities – for example, the utilization of digital data that we have in our healthcare system for research. We have opened the largest data treasure in the world for research by pharmaceutical companies. This is something that all other countries are now enviously looking at and is a great help for things.

We have also launched a pharmaceutical strategy, a medical research strategy, which now makes it possible for many, many approval processes to be much easier. I was surprised when I heard that some have to involve 50 ethics committees to get their respective research approved and that everything takes so long. I compared this with other countries and had many of them write letters with very concrete demands on how to change this and what needs to be done in detail to gain speed and improve the framework conditions.

For me, this is also a great encouragement; because we see that these two things – on the one hand, the opening of the data treasure for research and on the other hand, the medical research strategy, the pharmaceutical strategy ‑ with the facilitation of framework and approval conditions have led to the fact that now almost without subsidies – I could even have said one hundred percent, but I believe it is only 98 percent – billion-euro investments are taking place in the pharmaceutical location Germany. This is a great progress for which we have worked hard for a long time. And that is why I am always pleased with the many invitations to the groundbreaking ceremonies for new factories in Germany; because the greenfield investments in this area are already very impressive, and I wish for more of that – also for the entire chemical industry.

To reiterate regarding the pharmaceutical industry: Trust has led to the fact that the pharmaceutical sector has generated 95 billion euros in gross value added in recent years, and the companies employ more than one million workers in Germany. This is important. Investments are being made in new high-tech locations, and many new additional jobs are being created there.

With our growth initiative, which the federal government has now launched, we are creating incentives for private investments and easier access to venture capital – so that not only good ideas come from Germany, but that we also succeed in growing here and making money here. By the way, this is a topic that concerns me; because I once looked at figures for all of Europe and found that this is not a German problem, but rather a European issue: What actually happens to the companies that grow from small sizes, the “unicorns,” as it is said? One statistic told us: Of 120 European “unicorns,” 40 have gone to the USA due to better financing conditions. This has nothing to do with state activity, but it does relate to the question: How do we actually transfer the many funds that are available in Europe into entrepreneurial investments, so that money flows into the companies and they grow?

We are firmly committed to setting the framework conditions so that everything works legislatively as much as possible, and that we do everything we can to ensure that what is central for Europe and thus also for us in Germany really succeeds, namely that not only many speeches are made about reducing bureaucracy, but that this actually proceeds with speed and planning acceleration and that we can achieve this – one can see the successes, and we will continue. This also applies with regard to the long discussion about banks and capital market union: We need a difference from what we currently find in Europe and what is a core element of Europe’s growth weakness compared to the USA, namely that we have a capital market that is equipped with less equity, where less is invested through equity and through increasing participation in companies and where less is financed through equity growth. We are much more oriented towards credit financing through banks. This is something we need to change. We cannot change this alone, but it now has the highest priority so that we can exploit all growth opportunities here in Europe and especially in Germany. This is a joint endeavor with the French President, and the Commission President has also put it on the agenda. Now, from the many, many speeches that have been held on this, something must finally follow that can be translated into action.

Ladies and gentlemen, anyone who wants to make progress must want to do so here in Germany. This must be our common goal, and for this, we are politically setting the course. This includes the chemical and pharmaceutical strategy, the growth initiative, and also the electricity price compensation – I just mentioned all of this. But of course, we also need courage, entrepreneurial spirit, and confidence.

And one more thing we must absolutely defend: our openness to the world, which populists on the far right and far left are increasingly calling into question. You found clear words for this in a guest article in the “WELT” at the end of last year, Mr. Große Entrup. This is important because we are an export country that benefits from a connected global economy. The European internal market alone provides us in Germany with an annual prosperity gain of 1,000 euros per capita. I advocate that we actively promote new free trade agreements internationally and that the standstill that has occurred in Europe over the past decades comes to an end. I once said this at an event – and I am happy to repeat it here –: We did not hand over the competence to conclude trade agreements to the European Union so that no more agreements would be concluded, but because we expected the opposite from it. This must finally happen.

I have now written a letter to the new old Commission President with some European heads of state and asked her to push this forward. We have also devised a strategy that we are working on intensively here in Germany, on how we can actually ensure that individual countries cannot always block these agreements and that ratification does not take so long. There are ways to do this, and we simply have to dare to take new paths here so that this happens. The importance of Europe can only be maintained by engaging in trade with the whole world and by utilizing the opportunities it has with its own strength. This should also be underscored by such agreements.

Ladies and gentlemen, we are an economy that benefits from investments from abroad, and also from women and men here in Germany – this is also part of openness to the world. Anyone who claims otherwise, who wishes for companies to fail because they advocate for openness and tolerance, who speaks ill of Germany for political reasons, has me as their toughest opponent – and I know I am in good company with the VCI.

Wishing you much success for the Chemical & Pharma Summit and good discussions! All the best!